Benign Prostatic Hyperplasia
📧 Sign up to get email alerts when something new happens for Benign Prostatic Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-08-04Clinical Trial Update: ROPE Registry Project to Determine the Safety and Efficacy of Prostate Artery Embolisation (PAE) for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Enlargement (LUTS BPE).
This clinical trial registry update describes the ROPE project, a registry to assess the safety and effectiveness of prostate artery embolis…
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Efficacy and Safety of Tamsulosin/Solifenacin Combination Therapy in Patients With Voiding Symptoms and Moderate to Severe Storage Symptoms Due to Benign Prostate Hyperplasia [Phase 3]
Phase 3 trial update evaluating the efficacy and safety of a tamsulosin/solifenacin combination for voiding and storage symptoms in men with…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Investigate the Effect of Food on the Pharmacokinetic of JLP-1207 in Healthy Male Volunteers [Phase 1]
A Phase 1 study evaluated the impact of food on the pharmacokinetics of JLP-1207 in healthy male volunteers; the trial sponsored by Jeil Pha…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: The PK Study of the JLP-1207 and Solifenacin/Tamsulosin in Healthy Male Volunteers. [Phase 1]
This is a Phase 1 pharmacokinetic study of JLP-1207 alone and in combination with solifenacin and tamsulosin in healthy male volunteers. The…
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin [Phase 1]
A Phase 1 pharmacokinetic study evaluating potential drug interaction between solifenacin and tamsulosin has been completed. The study was s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-06-13FDA Approved: JALYN — Supplemental Application (Waylis Therapeutics)
The FDA approved a supplemental application for Jalyn, the combination of dutasteride and tamsulosin hydrochloride, submitted by Waylis Ther…
-
FDA approval · 2016-06-09FDA Approved: DOXAZOSIN — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for doxazosin from Mylan Pharmaceuticals, indicating a labeling or formulation update to the existin…
-
CLINICAL_TRIALS trial_result · 2016-05-20Clinical Trial Update: Combination of Metformine/Inulin Versus Metformin on Prostate Benign Hyperplasia in Metabolic Syndrome [Phase 3]
Phase 3 trial comparing metformin with inulin versus metformin alone for benign prostatic hyperplasia in patients with metabolic syndrome. T…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Ejaculatory Sparing vs. Non-ejaculatory Sparing GreenLight Laser Photoselective Vaporization of the Prostate [Phase 4]
Phase 4 clinical trial update comparing ejaculatory-sparing versus non-ejaculatory-sparing GreenLight laser photoselective vaporization of t…
-
FDA approval · 2016-04-22FDA Approved: CIALIS — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cialis (tadalafil) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Evaluation of Finastride Effect in Different Dosage on the Amount of Perioperative Bleeding in Transurthral Resection of Prostate [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated the effect of different doses of finasteride on perioperative bleeding during transurethral resection o…
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: Prostatic Artery Embolization for Benign Prostatic Hyperplasia [Phase 2, Phase 3]
A Phase 2/3 clinical trial of prostatic artery embolization for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS research · 2016-03-29Clinical Trial Update: Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency [Phase 4]
A Phase 4 clinical trial comparing HoLEP (Holmium Laser Enucleation) versus PVP (photoselective vaporization) for benign prostatic hyperplas…
-
FDA approval · 2016-03-23FDA Approved: UROXATRAL — Supplemental Application (Advanz Pharma (US) Corp.)
FDA approved a supplemental application for UROXATRAL (alfuzosin hydrochloride) submitted by Advanz Pharma (US) Corp., through a supplementa…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers [Phase 1]
Phase 1 PK and safety study of HCP1303 and co-administration of HGP1201 and HIP1402 under fed conditions in healthy male volunteers; the tri…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Study to Evaluate the Clinical Efficacy and Safety of Tamsulosin Alone or in Combination With Solifenacin for the Treatment in Men With Lower Urinary Tract Symptoms Including Overactive Bladder Symptoms [Phase 4]
Phase 4 trial evaluating tamsulosin alone or in combination with solifenacin for men with lower urinary tract symptoms including overactive …
-
CLINICAL_TRIALS trial_result · 2016-03-18Clinical Trial Update: Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers [Phase 1]
This Phase 1 trial evaluates the pharmacokinetics and safety of HCP1303 alone and in combination with HGP1201 and HIP1402 in healthy male vo…
-
CLINICAL_TRIALS withdrawal · 2016-03-04Clinical Trial Update: Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction [Phase 2]
Phase 2 trial evaluating udenafil for erectile dysfunction and benign prostatic hyperplasia has been withdrawn. No further development detai…
-
FDA approval · 2016-02-25FDA Approved: FINASTERIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Finasteride from Aurobindo Pharma Limited, enabling a generic Finasteride product.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS [Phase 3]
Phase 3 trial assessing the efficacy and safety of GL2702 GLARS-NF1tablet and Harnal-D Tablet in benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Bipolar Versus Monopolar Resection of Benign Prostate Hyperplasia [NA]
A clinical trial comparing bipolar versus monopolar resection techniques for benign prostatic hyperplasia has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: A Prospective Investigation Using the Expired Breath Ethanol Test
This document reports the completion of a prospective clinical investigation of the Expired Breath Ethanol Test in individuals with Benign P…
-
FDA approval · 2016-01-28FDA Approved: ALFUZOSIN HYDROCHLORIDE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for alfuzosin hydrochloride (generic) from Unichem Pharmaceuticals (USA), Inc. The approval covers its…
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms [Phase 3]
Phase 3 long-term trial evaluating the combination of solifenacin succinate and tamsulosin OCAS in men with lower urinary tract symptoms due…
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Study to Compare the Safety and Pharmacokinetics of CKD-397 [Phase 1]
Phase 1 study of CKD-397 evaluating safety and pharmacokinetics in Benign Prostatic Hyperplasia has completed.